Zila Zuckerman
- 所在地: イスラエル, ハイファ
Professor. Hematology and Transplantology Specialist
イスラエルのトップ非ホジキンリンパ腫医師と価格を比較。こちらで最適なマッチングを見つけてください
ご要望と予算に基づいて最適な医師を厳選いたします
医学的監修者 Fahad Mawlood
医学編集者・データサイエンティストトップ医師
2
イスラエル
レビュー
14000+
実際の患者より
個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし
Professor. Hematology and Transplantology Specialist
Specialist in the hematology. Specializes in the treatment of lymphomas.
海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。
ヤン・マツィイフスキー
医療コーディネーターチーム責任者
4300+件以上の患者の旅をガイド
Bookimedで3年
Israelの142名の患者が今月当社を通じて医師を見つけました
2分のクイズ
目標、予算、スケジュールをお聞かせください
人間のマッチング + AI
アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します
オプション準備完了
価格、パッケージ、日程を比較。コーディネーターとチャット
選択肢に迷っていますか?
治療をガイド
医療訓練を受けた専属コーディネーター






| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|
Top lymphoma specialists in Israel include Dr. Abraham Avigdor, Dr. Avichai Shimoni, and Prof. Zila Zuckerman. These board-certified experts lead major hematology institutes at Sheba and Rambam. They specialize in advanced CAR-T cell therapy and complex bone marrow transplants for non-Hodgkin’s lymphoma.
Bookimed Expert Insight: Lymphoma care in Israel stands out because leading specialists often hold dual roles. For example, Dr. Abraham Avigdor and Dr. Avichai Shimoni lead university departments alongside their clinic work. This ensures patients receive treatment based on the most recent 2025–2026 research protocols.
Patient Consensus: Patients emphasize the need for specialists who focus on specific lymphoma subtypes like follicular or mantle cell. They value fast responses when lab results show abnormal white blood cell counts.
Israeli hematologists have extensive experience treating all non-Hodgkin lymphoma types, from slow-growing follicular lymphoma to aggressive diffuse large B-cell lymphoma. Specialists like Dr. Abraham Avigdor and Dr. Avichai Shimoni at Sheba Medical Center lead the integration of advanced CAR-T cell therapies and complex bone marrow transplants.
Bookimed Expert Insight: Israeli specialists often hold subspecialty certifications from leading US institutions like MD Anderson or Memorial Sloan Kettering. This allows them to offer salvage chemotherapy and CAR-T therapy for cases that do not respond to standard protocols. Patients benefit from this global expertise combined with Israel's rapid adoption of new molecularly targeted drugs.
Patient Consensus: Patients value the ability of Israeli centers to provide advanced options like CAR-T therapy for hard-to-treat blood cancers. They frequently mention feeling supported by doctors who manage both the complex clinical protocols and the daily symptoms of treatment.
Doctors in Israel offer early access to innovative non-Hodgkin's lymphoma treatments like CAR-T cell therapy and personalized immunotherapy. Specialists such as Dr. Abraham Avigdor at Sheba Medical Center pioneer advanced protocols often available only through selected international clinical trials.
Bookimed Expert Insight: Israeli specialists often provide point-of-care CAR-T programs, which allow for faster treatment production in-house. This capability is concentrated at major hubs like Sheba Medical Center and Sourasky Medical Center, where leaders like Dr. Hila Magen run innovative clinical research trials alongside standard care.
Patient Consensus: Patients find that leading centers in Tel Aviv and Jerusalem offer advanced therapies like bispecific antibodies sooner than many other regions. Many noticed that while standard cases follow global rules, specialists quickly suggest newer options for relapsed lymphoma.
You can consult with an Israeli lymphoma specialist like Dr. Abraham Avigdor or Dr. Fredi Aviv via online video consultation before traveling. Leading hematologists at JCI-accredited centers like Sheba and Sourasky review your medical files and pathology reports to confirm your diagnosis and treatment plan remotely.
Bookimed Expert Insight: Israeli specialists often provide remote consultations for lymphoma cases even when they do not list standard online prices. Prof. Avichai Shimoni and Dr. Elad Jacoby at Sheba Medical Center prioritize pre-travel reviews for complex bone marrow transplant or CAR-T therapy candidates to ensure medical readiness.
Patient Consensus: Patients mention feeling much more relaxed after speaking with a specialist who already reviewed their files. They were surprised by how quickly doctors at centers like Sourasky organized the remote video call.
Israeli oncologists providing care for non-Hodgkin's lymphoma frequently speak English. Many top hematologists, such as Dr. Michael Shapira at Sourasky Medical Center, are fluent. Most specialists complete fellowships in the United States or Europe, which ensures they can discuss complex treatment plans in English.
Bookimed Expert Insight: Israeli specialists often have stronger English skills than doctors in other medical hubs. This is because many, like Dr. Ram Ron and Dr. Ronit El Hasid, lead units after years of training at top-tier U.S. research centers. When you book a private consultation, you are specifically matched with doctors comfortable communicating in English.
Patient Consensus: Patients found that while daily life in Israel varies, specialists in major hospitals all speak English for private appointments. They recommend arriving with your medical records and asking about team coordination to confirm care remains clear during backup coverage.
Personalized care for non-Hodgkin's lymphoma in Israel is defined by board-certified hemato-oncologists who use molecular diagnostics and adaptive treatment. Top specialists like Dr. Abraham Avigdor at Sheba Medical Center integrate personalized immunotherapy and CAR-T cell protocols based on each patient's unique genetic profile and response.
Bookimed Expert Insight: Israeli hemato-oncologists often hold double or triple board certifications in internal medicine, hematology, and oncology. This broad expertise allows them to manage the side effects of complex lymphoma treatments like bone marrow transplants more effectively than single-specialty doctors.
Patient Consensus: Patients often mention their specialists did not just follow standard chemotherapy but adjusted doses and drugs quickly. They felt relieved when doctors like Dr. Polina Stepensky explained rare conditions in simple terms during difficult transplants.